News

Adragos Pharma acquires Sanofi’s manufacturing site in Kawagoe, Japan

Adragos Pharma to acquire Sanofi’s manufacturing site in Kawagoe, Japan Munich / Paris / Tokyo, October 13, 2022 – Adragos Pharma, a rapidly growing pharmaceutical Contract Development and Manufacturing Organization (CDMO) based in Munich, Germany, signed definitive agreements with Sanofi […]

FSN Capital VI & Prange Group: Accelerating Adragos Pharma Growth

Munich / Plettenberg, 09. August 2021 – FSN Capital VI* (“FSNC”) has acquired a majority share in Adragos Pharma Group (“Adragos”), a growing B2B contract developer and manufacturer (CDMO) for pharmaceuticals. The current owner, Prange Group (“PG”), remains invested to […]

Subscribe to our newsletter!

Get notified on our latest news.